Verona Pharma plc (VRNA)
Oct 7, 2025 - VRNA was delisted (reason: acquired by MRK)
106.91
+0.12 (0.11%)
Inactive · Last trade price on Oct 6, 2025

Verona Pharma Revenue

Verona Pharma had revenue of $103.14M in the quarter ending June 30, 2025. This brings the company's revenue in the last twelve months to $221.67M. In the year 2024, Verona Pharma had annual revenue of $42.28M.

Revenue (ttm)
$221.67M
Revenue Growth
n/a
P/S Ratio
40.39
Revenue / Employee
$1,060,636
Employees
209
Market Cap
9.21B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202442.28M--
Dec 31, 2023---
Dec 31, 2022458.00K-39.54M-98.86%
Dec 31, 202140.00M--
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.